Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tsinghua Unigroup is a major Chinese technology conglomerate that maintains a significant presence in the healthcare and pharmaceutical sectors through its specialized subsidiaries. The company's healthcare arm, Unigroup Healthcare, focuses on digital health solutions, medical imaging, and hospital information systems to modernize clinical workflows. Additionally, its pharmaceutical division, Unigroup Pharmaceutical, is involved in the development, manufacturing, and commercialization of chemical drugs and traditional Chinese medicines. While primarily known for its semiconductor and IT business, Tsinghua Unigroup leverages its technological infrastructure to drive innovation in medical electronics and healthcare data management. The group operates as a diversified entity with a focus on integrating high-tech solutions into the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unigroup.